KeyBanc analyst Brent Bracelin reiterated an Overweight rating and $74 price target on Alteryx (NYSE: AYX), noting 60% billings growth ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE